UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
REDWOOD CITY, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a...
Filed by Mereo BioPharma Group plc pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company:...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDU...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Sche...
Filed by OncoMed Pharmaceuticals, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and...
UNITED STATES OMB APPROVAL ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Filed by Mereo BioPharma Group plc pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Compa...
FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.